Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Prostate Cancer Cell Line Transcriptomes

ABSTRACT: Prostate Cancer Cell Line Transcriptomes

PROVIDER: PRJNA871891 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21151909_1.fastq.gz	Fastqsanger.gz
	SRR21151909_2.fastq.gz	Fastqsanger.gz
	SRR21151910_1.fastq.gz	Fastqsanger.gz
	SRR21151910_2.fastq.gz	Fastqsanger.gz
	SRR21151911_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Next Generation Sequencing Facilitates Quantitative Analysis of prostate cancer cell line LNCaP Transcriptomes

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of prostate cancer cell line LNCaP Transcriptomes

| PRJNA675482 | ENA

Prostate Cancer Cell Line Transcriptomes

Project description:Gene expression of 5 prostate cancer cell lines (LNCaP, VCaP, DU-145, PC-3, DuCaP) in standard culture conditions, harvested during exponential growth phase.

2022-09-07 | GSE211721 | GEO

Gene expression profiling in prostate cancer cell line LNCaP.

Project description:Gene expression profiling in prostate cancer cell line LNCaP.

| PRJNA925483 | ENA

ATGL deletion in castration-resistant prostate cancer cell line

Project description:ATGL deletion in castration-resistant prostate cancer cell line

| PRJNA1016447 | ENA

ChIP-seq of HNF1B in prostate cancer cell line DU145

Project description:ChIP-seq of HNF1B in prostate cancer cell line DU145

| PRJNA761335 | ENA

Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment

Project description:Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment

| PRJNA491894 | ENA

Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment

Project description:Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment

| PRJNA523525 | ENA

Transcription profiling of human prostate cancer primary cell line vs metastasis cell line reveals Protein 4.1B suppresses prostate cancer progression and metastasis

Project description:Protein 4.1B is a 4.1/ezrin/radixin/moesin (FERM) domain-containing protein whose expression is frequently lost in a variety of human tumors, including meningiomas, non-small-cell lung cancers and breast carcinomas. However, its potential tumor suppressive function under in vivo conditions remains to be validated. In a screen for genes involved with prostate cancer metastasis, we found that 4.1B expression is reduced in highly metastatic tumors. Downregulation of 4.1B increased the metastatic propensity of poorly metastatic cells in an orthotopic model of prostate cancer. Furthermore, 4.1B-deficient mice displayed increased susceptibility for developing aggressive, spontaneous prostate carcinomas. In both cases, enhanced tumor malignancy was associated with reduced apoptosis. As expression of Protein 4.1B is frequently downregulated in human clinical prostate cancer, as well as in a spectrum of other tumor types, these results suggest a more general role for Protein 4.1B as a negative regulator of cancer progression to metastatic disease. Experiment Overall Design: primary cell line vs metastasis cell line

2008-06-15 | E-GEOD-7930 | biostudies-arrayexpress

siRNA mediated HDAC1 knockdown in the LNCaP prostate cancer cell line

Project description:siRNA mediated HDAC1 knockdown in the LNCaP prostate cancer cell line.

2021-03-01 | GSE159839 | GEO

Expanding the prostate cancer cell line repository: insights into the first Caribbean cell line, ACRJ-PC28

Project description:Expanding the prostate cancer cell line repository: insights into the first Caribbean cell line, ACRJ-PC28

| PRJNA879775 | ENA